Eye Drop
Drip drop, tick tock: Are presbyopia drops turning back the clock?
Ocuphire initiates phase 3 study of Nyxol for night vision disturbances
Moderate to severe dry eye improves after treatment with PL9643 in phase 2 study
VIDEO: Pilocarpine drives improvement in near vision in phase 2 studies
VIDEO: Brimochol shows increased visual acuity in clinical data
VIDEO: Presbyopia eye drop improves uncorrected near visual acuity
Phase 2b trial for Aerie dry eye drop begins
Of the upcoming new approaches, what do you expect to be the best for the treatment of early presbyopia?

There is a lot of excitement around the new eye drops for presbyopia, which should hopefully become available in the U.S. in the next 1 to 2 years. The beauty of this pharmacological option is that patients can try the drops and determine how effective they are and how well they tolerate them before committing to long-term use. It is the least invasive and easiest way to reverse the symptoms of presbyopia and reduce the need for reading glasses, with no known long-term downside or risk. Once available, patients will have the option to trial these medications. If not satisfied with the level of improvement in reading vision, or if the side effects are not well tolerated, patients can, of course, elect surgical options to improve their reading vision.